Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Further characterization of the bronchodilating effects of Ro-25-1553 in human preparations

Dec. 5, 2001

Banyu patents selective muscarinic M3 receptor antagonists

Dec. 3, 2001

Active vaccination against IL-5 as a novel approach to asthma

Dec. 3, 2001

SB-265610: a nonpeptide CXCR2 antagonist effective against neutrophil accumulation

Dec. 3, 2001

Age limit lowered for participation in phase II trial of tgAAVCF in cystic fibrosis

Dec. 3, 2001

Zenapax enters phase II trial in patients with chronic asthma

Dec. 3, 2001

Rigel receives milestone from Pfizer for respiratory drug target validation

Nov. 30, 2001

Sheffield initiates budesonide inhalation suspension study

Nov. 27, 2001

Anti-CCR2 antibodies reported in recent patent by Millennium

Nov. 23, 2001

Pyridyl-thiazolyl compounds for PDE4-mediated conditions

Nov. 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.